Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "innovation"

2021 News Found

Sigachi Industries achieves key R&D milestone in Cystic Fibrosis APIs
R&D | January 21, 2026

Sigachi Industries achieves key R&D milestone in Cystic Fibrosis APIs

The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments


Kindeva appoints David Stevens as new CEO
People | January 20, 2026

Kindeva appoints David Stevens as new CEO

Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors


Avalon clinches majority investment to expand future of diagnostic intelligence
News | January 20, 2026

Avalon clinches majority investment to expand future of diagnostic intelligence

The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities


IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis
Biotech | January 20, 2026

IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis

The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability


Syngene locks in Bristol Myers Squibb alliance through 2035
News | January 20, 2026

Syngene locks in Bristol Myers Squibb alliance through 2035

The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle


Manthan 2026 wraps up, spotlighting India’s life sciences & clinical research future
News | January 20, 2026

Manthan 2026 wraps up, spotlighting India’s life sciences & clinical research future

India in the Changing Landscape of Life-Sciences Research & Development


Boston Scientific to acquire Penumbra in $14.5 billion deal
News | January 17, 2026

Boston Scientific to acquire Penumbra in $14.5 billion deal

Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion


WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing
Digitisation | January 16, 2026

WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing

The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing


Alphatec and Theradaptive forge landmark spine partnership as Series B round launches
News | January 16, 2026

Alphatec and Theradaptive forge landmark spine partnership as Series B round launches

ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications


Avantium and Packamama join forces to revolutionise wine packaging with plant-based polymer
Packaging | January 16, 2026

Avantium and Packamama join forces to revolutionise wine packaging with plant-based polymer

The partnership aims to fuse Avantium’s breakthrough materials with Packamama’s expertise in low-emission, innovative wine bottles